Peptide Complement Inhibitors

Peptide Complement Inhibitors is a class of therapeutic peptides that selectively modulate the activity of the complement system by targeting specific components or activation pathways, thereby distinguishing themselves from other complement inhibitory agents through their peptidic structure and mechanism of molecular interaction.

71

Publications

3K

Citations

328

Authors

101

Institutions

Publications per year

2017–2026

6

Authors

328

  1. JD
    John D. Lambris

    University of Pennsylvania, United States

    14 publications · 1.3K citations

    13

    h-index

  2. DM
    Dimitrios Morikis

    University of California, Riverside, United States

    11 publications · 480 citations

    11

    h-index

  3. NK
    Neel K. Krishna

    Eastern Virginia Medical School, United States

    8 publications · 251 citations

    8

    h-index

  4. KM
    Kenji M. Cunnion

    Eastern Virginia Medical School, United States

    8 publications · 251 citations

    8

    h-index

  5. PS
    Pamela S. Hair

    Eastern Virginia Medical School, United States

    8 publications · 251 citations

    8

    h-index

1–5 of 328

Venues

  1. The Journal of Immunology

    JI · 13 publications · 833 citations

    12

    h-index

  2. Molecular Immunology

    8 publications · 304 citations

    8

    h-index

  3. Journal of Medicinal Chemistry

    4 publications · 174 citations

    4

    h-index

  4. Chemical Biology & Drug Design

    3 publications · 64 citations

    3

    h-index

  5. PLoS ONE

    3 publications · 70 citations

    3

    h-index

1–5